Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ)
CNY 7.48
(0.67%)
CNY 7.48
(0.67%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 40.95 Million CNY | 597.92% |
| 2022 | 5.86 Million CNY | -46.4% |
| 2021 | 10.94 Million CNY | -78.62% |
| 2020 | 51.2 Million CNY | 1306.9% |
| 2019 | 3.63 Million CNY | 3.61% |
| 2018 | 3.51 Million CNY | -1.51% |
| 2017 | 3.56 Million CNY | -94.06% |
| 2016 | 60.01 Million CNY | 5.8% |
| 2015 | 56.72 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | -100.0% |
| 2010 | 77.5 Million CNY | 604.55% |
| 2009 | 11 Million CNY | 0.0% |
| 2008 | - CNY | -100.0% |
| 2007 | 25 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 57.75 Thousand CNY | -99.77% |
| 2024 Q2 | 26.5 Million CNY | -8.06% |
| 2024 Q1 | 28.82 Million CNY | -29.61% |
| 2023 Q3 | 53.79 Million CNY | 35.62% |
| 2023 FY | 40.95 Million CNY | 597.92% |
| 2023 Q4 | 40.95 Million CNY | -23.88% |
| 2023 Q2 | 39.66 Million CNY | 671.27% |
| 2023 Q1 | 5.14 Million CNY | -12.35% |
| 2022 Q3 | 12.3 Million CNY | 20.15% |
| 2022 Q1 | 10.39 Million CNY | -5.02% |
| 2022 Q2 | 10.23 Million CNY | -1.54% |
| 2022 FY | 5.86 Million CNY | -46.4% |
| 2022 Q4 | 5.86 Million CNY | -52.3% |
| 2021 Q2 | 12.14 Million CNY | -79.97% |
| 2021 Q4 | 10.94 Million CNY | -6.31% |
| 2021 FY | 10.94 Million CNY | -78.62% |
| 2021 Q3 | 11.68 Million CNY | -3.82% |
| 2021 Q1 | 60.65 Million CNY | 18.46% |
| 2020 FY | 51.2 Million CNY | 1306.9% |
| 2020 Q1 | 3.67 Million CNY | 0.89% |
| 2020 Q2 | 51.7 Million CNY | 1308.06% |
| 2020 Q3 | 54.58 Million CNY | 5.56% |
| 2020 Q4 | 51.2 Million CNY | -6.19% |
| 2019 FY | 3.63 Million CNY | 3.61% |
| 2019 Q4 | 3.63 Million CNY | 0.9% |
| 2019 Q3 | 3.6 Million CNY | 0.89% |
| 2019 Q1 | 3.54 Million CNY | 0.89% |
| 2019 Q2 | 3.57 Million CNY | 0.88% |
| 2018 Q2 | 3.89 Million CNY | 4.36% |
| 2018 Q1 | 3.72 Million CNY | 4.56% |
| 2018 Q4 | 3.51 Million CNY | -0.07% |
| 2018 Q3 | 3.51 Million CNY | -9.68% |
| 2018 FY | 3.51 Million CNY | -1.51% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 FY | 3.56 Million CNY | -94.06% |
| 2017 Q4 | 3.56 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q3 | 6.67 Million CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 FY | 60.01 Million CNY | 5.8% |
| 2016 Q4 | - CNY | -100.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 FY | 56.72 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 FY | - CNY | -100.0% |
| 2011 Q2 | - CNY | -100.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q1 | 77.5 Million CNY | 0.0% |
| 2010 Q4 | 77.5 Million CNY | 0.0% |
| 2010 FY | 77.5 Million CNY | 604.55% |
| 2010 Q3 | 77.5 Million CNY | 0.0% |
| 2009 FY | 11 Million CNY | 0.0% |
| 2008 FY | - CNY | -100.0% |
| 2007 FY | 25 Million CNY | 0.0% |